Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Abstract Text:

    hidefumi sasakiHidefumi Sasaki,katsuhiro okudaKatsuhiro Okuda,osamu kawanoOsamu Kawano,katsuhiko endoKatsuhiko Endo,haruhiro yukiueHaruhiro Yukiue,tomoki yokoyamaTomoki Yokoyama,motoki yanoMotoki Yano,yoshitaka fujiiYoshitaka Fujii,

    Activating mutations of Ras gene families have been found in a variety of human malignancies, including lung cancer, suggesting their dominant role in tumorigenesis. Many studies have showed that the Kras gene is activated by point mutations in approximately 15-20% of non-small cell lung cancers (NSCLCs), however, there are only a few reports on Nras mutations in NSCLC. We have genotyped Nras mutation status (n=195) and Kras mutation status (n=190) in surgically treated lung adenocarcinoma cases. The presence or absence of Nras and Kras mutations was analyzed by real-time quantitative polymerase chain reaction (PCR) with mutation-specific sensor and anchor probes. EGFR mutation status at kinase domain has already been reported. Nras mutation was found in 1 of 195 patients. This mutation was a G-to-T transversion, involving the substitution of the normal glycine (GGT) with cystein (TGT) and thought to be a somatic mutation. The patient was male and a smoker. Kras mutant patients (11.1%; 21/190) had a significantly worse prognosis than wild-type patients (p=0.0013). Eighty-two EGFR mutations at kinase domain had exclusively Nras or Kras mutations. Although Nras gene mutation might be one of the mechanisms of oncogenesis of lung adenocarcinoma, this was a very rare event. Further studies are needed to confirm the mechanisms of Nras mutations for the sensitivity of molecular target therapy for lung cancer.

    Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Publishing Authors By Initials

    h sasakiH Sasaki,k okudaK Okuda,o kawanoO Kawano,k endoK Endo,h yukiueH Yukiue,t yokoyamaT Yokoyama,m yanoM Yano,y fujiiY Fujii,

    For similar enzymes and coenzymes: enzymes: hydrolases: acid anhydride hydrolases: gtp phosphohydrolases: gtp-binding proteins: monomeric gtp-binding proteins: ras proteins research abstracts see: enzymes and coenzymes: enzymes: hydrolases: acid anhydride hydrolases: gtp phosphohydrolases: gtp-binding proteins: monomeric gtp-binding proteins: ras proteins research

    PUBMED ID PMID:

    MEDLINE DATE:

    Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Oncology reports

    VOLUME: 18

    Page Numbers: 623-8

    Journal Abbreviation: Oncol. Rep.

    ISSN: 1021-335X

    DAY: 28

    MONTH: Sep

    YEAR: 2007

    Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9422756

    Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Keywords Mesh Terms:

    KEYWORDS: ras Proteins

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Information

    Substance Name: ras Proteins

    Registry Number: EC 3.6.5.2

    Grant and Affiliation Information for Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

    AFFILIATION: Department of Surgery II, Nagoya City University Medical School, Nagoya 467-8601, Japan. hisasaki@med.nagoya-cu.ac.jp

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Oncol Rep

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News